Promising new therapeutic approach for treating metastatic pancreatic cancer
A research paper published in Nature Cancer details new insights into the role of efferocytosis – the…
A research paper published in Nature Cancer details new insights into the role of efferocytosis – the…
Studies have shown that utilising a PARP inhibitor in the management of patients with metastatic…
Scientists at Sanford Burnham Prebys Medical Discovery Institute, USA, have shown that pancreatic cancer metastasis…
Patients with metastatic pancreatic cancer who had germline or somatic mutations in DNA repair genes…
The randomised, phase III POLO trial found that maintenance therapy with the PARP inhibitor olaparib…